|
Tumor Microenvironment: Progression, Therapy and Prevention
|
1R13CA128588-01
|
$10,000
|
$2,500
|
DeClerck, Yves
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$118,647
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$38,400
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Molecular Mechanisms by which Rexinoids Prevent BRCA
|
5R01CA078480-10
|
$337,707
|
$337,707
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prevention of ER-negative Breast Cancer: Identification*
|
5R01CA101211-05
|
$475,923
|
$475,923
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Prostate Cancer
|
3P50CA058204-13S1
|
$1,124,001
|
$224,800
|
ITTMANN, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$5,585
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
3P50CA058183-13S1
|
$153,479
|
$38,370
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-13
|
$2,612,827
|
$653,207
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targets of Vitamin D Receptor Action in Prostate
|
5R01CA107691-04
|
$292,538
|
$292,538
|
Weigel, Nancy
|
BAYLOR COLLEGE OF MEDICINE
|
|
Soy Isoflavone Supplementation and Mammographic Density in Postmenopausal Women
|
5R03CA121879-02
|
$75,007
|
$75,007
|
WONG, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$6,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$31,280
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Synergy between phytochemicals for prostate cancer prevention
|
1R03CA130133-01
|
$85,000
|
$85,000
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
In utero availability of the essential nutrient, choline, and mammary cancer risk
|
1R21CA120488-01A1
|
$195,000
|
$97,500
|
BLUSZTAJN, JAN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Imaging Evaluation of Cancer Chemoprevention
|
5R21CA106399-02
|
$149,898
|
$149,898
|
WANG, ZHI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
$1,666,176
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-04S1
|
$87,500
|
$17,500
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
5P50CA105009-04
|
$2,278,757
|
$455,751
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
2R01CA097193-06A1
|
$1,550,473
|
$1,550,473
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calcium Channel CaT 1 in Prostate Cancer Prevention
|
5R01CA101075-05
|
$284,455
|
$142,228
|
Hsu, Stephen
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mouse Models for Human Cancer
|
5U01CA084301-09
|
$936,359
|
$140,454
|
KUCHERLAPATI, RAJU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nutiritional and Biochemical/Genetic Markers of Cancer
|
5R01CA042182-20
|
$714,410
|
$714,410
|
Ma, Jing
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A Pilot Trial of Oral Melatonin Supplementation in Breast Cancer Survivors
|
5R03CA123597-02
|
$84,574
|
$84,574
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nutritional and Genetic Markers of Breast Cancer
|
5R01CA104871-03
|
$283,780
|
$283,780
|
ZHANG, SHUMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Technical Information Research Resources for Cancer Preventive Agent Development
|
N02CN433015-003
|
$2,478,780
|
$2,478,780
|
SIGMAN, CAROLINE
|
C C S Associates Inc
|
|
Nutritional Intervention Trials in Linxian China-Continued Follow-Up
|
N01RC477001-002
|
$58,949
|
$58,949
|
DONG, ZHI-WEI
|
Cancer Inst (Hos) Chinese Acad. Med Scie
|
|
Early Detection of Esophageal Cancer
|
N01RC477002-002
|
$200,000
|
$50,000
|
DONG, ZHI-WEI
|
Cancer Inst (Hosp) Chinese Acad. Med Sch
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
$1,146,823
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Selenium Based Chemoprevention - HGPIN
|
5U01CA077178-11
|
$1
|
$1
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Carle Cancer Center Community Clinical Oncology Program
|
3U10CA035195-24S1
|
$120,000
|
$9,600
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-24
|
$693,116
|
$55,449
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
$357,280
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of GSTP1 Reactivation by Green Tea Polyphenols
|
1R01CA115491-01A2
|
$283,195
|
$283,195
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of Prostate Ca. Chemoprevention by Apigenin
|
5R01CA108512-04
|
$228,488
|
$228,488
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Determinants of Chemoprevention by SERMs
|
1R03CA130066-01
|
$77,250
|
$77,250
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Retinoic acid, CRABP, and cancer
|
7R01CA107013-03
|
$369,295
|
$369,295
|
NOY, NOA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT
|
N02CN433011-004
|
$1,184,647
|
$1,184,647
|
SIGMAN, CAROLINE
|
CCS ASSOCIATES INC
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-18
|
$423,530
|
$33,882
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Multi-Center Study of Pancratic Cancer Etiology
|
5R01CA102765-04
|
$1,131,891
|
$226,378
|
POTTER, JOHN
|
CENTER FOR HEALTH STUDIES
|
|
Assessing the Impact of Colorectal Cancer Screening
|
5U01CA097427-06
|
$213,789
|
$74,826
|
RUTTER, CAROLYN
|
CENTER FOR HEALTH STUDIES
|
|
Action of Novel Retinyl Ethers in Breast Cancer Control
|
5R01CA108498-04
|
$281,848
|
$281,848
|
SANI, BRAHMA
|
CHEMOPREVENTIA, LLC
|
|
Chemoprevention of Basal Cell Carcinomas with Tazarotene
|
7R01CA109584-04
|
$984,967
|
$984,967
|
EPSTEIN, ERVIN
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
1R01CA129438-01A1
|
$319,440
|
$79,860
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
METALLOPROTEINASE INHIBITORS IN TUMOR PROGRESSION
|
5R01CA042919-19
|
$253,961
|
$83,807
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeting RhoA Lymphomagenesis
|
5R03CA125830-02
|
$72,825
|
$72,825
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Development of CpG oligodeoxynucleotides as adjuvant chemotherapy for ALL
|
5R03CA123554-02
|
$80,108
|
$80,108
|
Reid, Gregor
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
2U10CA045418-21
|
$835,003
|
$66,800
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Delaware/Christiana Care CCOP
|
3U10CA045418-21S1
|
$119,011
|
$9,521
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
Total relevant funding to Chemoprevention for this search: $184,297,242
|